Requirements for CONSA partner sites
| Role . | Essential elements . |
|---|---|
| Site leadership | One qualified National Coordinator must be identified to represent all CONSA participants within a single country. This individual must reside in the member country and must demonstrate leadership characteristics necessary to advance the mission of the consortium. |
| Bloodspot sampling, handling, and testing | The ability to perform population-based newborn sample collection, timely transport to, and testing by 1 or more in-country central laboratory(ies) for hemoglobinopathy testing by isoelectric focusing (IEF). |
| Clinical services | Access to an established clinical care center for babies identified with SCD to receive standardized care, including availability of folic acid, antimicrobial prophylaxis with penicillin, and antimalarial chemoprophylaxis (or insecticide-treated bed nets [ITNs]). |
| Immunization services | Access to an established public health immunization program, including standard early childhood vaccines and vaccines against Pneumococcus and Haemophilus influenzae type B (Hib). |
| Family support | Ability to provide adequate family education and counseling services for babies screened and enrolled in the consortium protocol. |
| Institutional review board–approved program implementation | Local and/or national support for program implementation in 1 or more defined catchment areas, including institutional review board approval before implementation for conduct of human participant research. |
| Database | Data management capacity and agreement to use the CONSA database. |
| QA and QI | Willingness to participate in program quality control and interventions, as needed. |
| Role . | Essential elements . |
|---|---|
| Site leadership | One qualified National Coordinator must be identified to represent all CONSA participants within a single country. This individual must reside in the member country and must demonstrate leadership characteristics necessary to advance the mission of the consortium. |
| Bloodspot sampling, handling, and testing | The ability to perform population-based newborn sample collection, timely transport to, and testing by 1 or more in-country central laboratory(ies) for hemoglobinopathy testing by isoelectric focusing (IEF). |
| Clinical services | Access to an established clinical care center for babies identified with SCD to receive standardized care, including availability of folic acid, antimicrobial prophylaxis with penicillin, and antimalarial chemoprophylaxis (or insecticide-treated bed nets [ITNs]). |
| Immunization services | Access to an established public health immunization program, including standard early childhood vaccines and vaccines against Pneumococcus and Haemophilus influenzae type B (Hib). |
| Family support | Ability to provide adequate family education and counseling services for babies screened and enrolled in the consortium protocol. |
| Institutional review board–approved program implementation | Local and/or national support for program implementation in 1 or more defined catchment areas, including institutional review board approval before implementation for conduct of human participant research. |
| Database | Data management capacity and agreement to use the CONSA database. |
| QA and QI | Willingness to participate in program quality control and interventions, as needed. |